Literature DB >> 3438896

Cystic fibrosis in adolescents and adults.

A R Penketh1, A Wise, M B Mearns, M E Hodson, J C Batten.   

Abstract

Three hundred and sixteen patients with cystic fibrosis were seen at the Brompton Hospital during 1965-83; 178 (56.3%) of them were male and 136 female, and their ages ranged from 12 to 51 years. Most patients presented in infancy with respiratory symptoms and malabsorption, but 19 (6%) were diagnosed in adult life, three in their 30s. Pulmonary disease was almost universal (99.7%), being responsible for 97% of all deaths and three quarters of hospital admissions. All patients had developed a productive cough by the age of 21 and over half before the age of 5. Many complained of wheezing, but reversible airflow obstruction was present in only 40% of those tested. Minor haemoptysis was very common (62%), but major episodes less so (10%). Pneumothorax was seen in 61 cases (19%), and was often recurrent. Some irreversible airflow obstruction was present in all patients with pulmonary disease. Two patients have been followed for over 20 years without showing appreciable decline in lung function. Thirty five patients (11%) had no symptoms of malabsorption. Acute meconium ileus equivalent was seen in 16% and a chronic partial obstruction with episodic symptoms in a further 19%. Diabetes mellitus developed in 36 patients, 13 of whom were insulin dependent. Hepatomegaly was common (29%), often occurring without abnormal results in biochemical tests of liver function; only 1% of patients developed portal hypertension with varices and ascites. Skin reactions to at least one common allergen, including Aspergillus fumigatus, were positive in 70%, but very few patients suffered from hay fever or eczema. One hundred and twenty one patients have died, 97% from infection or other pulmonary complications, and 195 were alive in December 1983 (mean age 23 years). Seventy eight per cent of patients were in full time education or full or part time employment, or were housewives, and only 41 were unemployed for reasons for health. Many patients are married and 10 women have borne children. Most patients were admitted to hospital only three or four times during the period of follow up and 50 individuals (16%) have never been in hospital at all. The improvement in prognosis and quality of life for adults with cystic fibrosis should encourage a positive attitude in those who care for them.

Entities:  

Mesh:

Year:  1987        PMID: 3438896      PMCID: PMC460820          DOI: 10.1136/thx.42.7.526

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

Review 2.  Cystic fibrosis.

Authors:  R E Wood; T F Boat; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1976-06

Review 3.  Cystic fibrosis of the pancreas in adolescence and adulthood.

Authors:  M Gracey; C M Anderson
Journal:  Australas Ann Med       Date:  1969-05

4.  Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature.

Authors:  P A di Sant'agnese; P B Davis
Journal:  Am J Med       Date:  1979-01       Impact factor: 4.965

5.  Management of pneumothorax in adults with cystic fibrosis.

Authors:  A R Penketh; R K Knight; M E Hodson; J C Batten
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

6.  Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome.

Authors:  R C Stern; T F Boat; C F Doershuk
Journal:  Lancet       Date:  1982-06-19       Impact factor: 79.321

7.  Cystic fibrosis in adolescents and adults.

Authors:  P Mitchell-Heggs; M Mearns; J C Batten
Journal:  Q J Med       Date:  1976-07

8.  Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption.

Authors:  K Gaskin; D Gurwitz; P Durie; M Corey; H Levison; G Forstner
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

9.  Cystic fibrosis: a new outlook. 70 patients above 25 years of age.

Authors:  H Shwachman; M Kowalski; K T Khaw
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

10.  Lingual lipase: an important lipase in the digestion of dietary lipids in cystic fibrosis?

Authors:  B Fredrikzon; L Bläckberg
Journal:  Pediatr Res       Date:  1980-12       Impact factor: 3.756

View more
  35 in total

1.  Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.

Authors:  R H Lawrence; T C Sorrelli
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Heart-lung transplantation for cystic fibrosis.

Authors:  B P Madden; M E Hodson; M H Yacoub; E W Alton; P J Barnes; D M Denison; A B Kay; A Newman-Taylor; D M Geddes
Journal:  BMJ       Date:  1992-03-28

Review 3.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

4.  Glucose tolerance in cystic fibrosis.

Authors:  S Lanng; B Thorsteinsson; G Erichsen; J Nerup; C Koch
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

5.  Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial.

Authors:  A J Moorcroft; M E Dodd; J Morris; A K Webb
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

6.  Life threatening haemoptysis in cystic fibrosis: an alternative therapeutic approach.

Authors:  D Bilton; A K Webb; H Foster; P Mulvenna; M Dodd
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

7.  Microparticles for inhalational delivery of antipseudomonal antibiotics.

Authors:  Michael D Tsifansky; Yoon Yeo; Oleg V Evgenov; Evangelia Bellas; John Benjamin; Daniel S Kohane
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

8.  Exercise testing and prognosis in adult cystic fibrosis.

Authors:  A J Moorcroft; M E Dodd; A K Webb
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

9.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

10.  Exercise testing in patients with cystic fibrosis-importance of ventilatory parameters.

Authors:  Matthew A Tucker; Nichole Lee; Paula Rodriguez-Miguelez; Jacob Looney; Reva H Crandall; Caralee Forseen; Kathleen T McKie; Ryan A Harris
Journal:  Eur J Appl Physiol       Date:  2018-10-24       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.